New class of drugs may help tackle resistant cancers


Team Udayavani, Apr 12, 2018, 3:00 PM IST

London: Researchers have discovered a new class of drugs that could help treat cancer patients who no longer respond to existing therapies. The drug may not become available to patients for a number of years yet, but researchers at Imperial College London in the UK believe that if clinical trials are successful, it could be used to tackle a variety of treatment-resistant cancers.

Patients with breast cancer for example frequently become resistant to existing hormone-based treatments, leading to the disease becoming fatal. Early lab-based tests of ICEC0942 were successful in targeting resistant breast cancers and indicated minimal side effects, according to the results published in the journal Molecular Cancer Therapeutics.

ICEC0942 was then licenced to Carrick Therapeutics, who developed it into a molecule named CT7001, which they have taken to early-stage clinical trials in less than two years. “Treatment-resistant tumours represent a significant threat for patients, as once cancer stops responding to treatments there is increasingly little clinicians can do,” said Charles Coombes, a professor at Imperial College London.

“Drugs such as these could help to shift the balance back in favour of the patients, potentially providing a new option to patients for who existing treatments no longer work,” said Coombes. The drug targets an enzyme called CDK7, involved in directing cells through their life-cycle, which consists of growth, DNA replication and cell division.

CDK7 is also involved in the process of transcription, a vital step in gene expression – the creation of proteins to carry out cell functions. Particular cancers, such as treatment-resistant breast cancers, have a unique dependence on transcription, meaning targeting CDK7 may be particularly effective.

By inhibiting transcription, ICEC0942 shuts down the ability of the cancer to spread. As well as breast cancers, cancers such as acute myeloid leukaemia and small-cell lung cancer are particularly transcription-dependent, so ICEC0942 may work well for these too, especially where they have become resistant to other treatments.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

MUDA case: BJP protests demanding K’taka CM’s resignation after he appears before Lokayukta police

Kaup: Techies grow Kashmiri saffron in coastal land, Achieve initial success

Original East India Company wound up but new breed of monopolists is in its place: Rahul

Pune gangrape case: 2 arrested men gave false info about 3rd absconding accused, say police

A third of Ranthambore’s 75 tigers missing, say officials

‘This will be most important day in American history’: Trump

EC updates Maharashtra voter list; Shahada seat has 3 candidates in fray, Nanded North 33

Related Articles More

Weight loss could help one manage PCOS symptoms, study suggests

Risk of abnormal blood fat levels increased by about 30 pc during pandemic, finds study

Attention problems could be ‘middleman’ between genetic risk for, experiencing psychosis: Study

Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study

Meeting WHO’s sodium recommendations could avert deaths from heart, kidney disease: Study

MUST WATCH

Gho Pooja in Deepavali Festival

Melukote Deepavali

Ganapathi Co-operative Society Ltd

Udayavani Chinnara Banna 2024

Annapoorna Aahar | Food Places In Mysore


Latest Additions

MUDA case: BJP protests demanding K’taka CM’s resignation after he appears before Lokayukta police

Bajpe: Fog causes flight delays, diversions at Mangaluru Airport

David Warner says Cricket Australia ‘squashed’ ball change issue ‘as fast as they could’

Kundapura: Man gets 20-year sentence for assaulting minor girl

Bengaluru: Man, working as ward helper, arrested for secretly recording women in hospital restroom

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.